Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
China Journal of Chinese Materia Medica ; (24): 1632-1637, 2008.
Article in Chinese | WPRIM | ID: wpr-264880

ABSTRACT

To investigate the historical origins of folk herbal medicine 'Xuelihua', the origin of 'Xuelihua' was confirmed by textural, botanical characteristics research, investigation of therapeutic effects and field survey. The 'Xuelihua' which was originally recorded in 'Bencao Gangmu Shiyi' (A Supplement to the Compendium of Materia Medica) should be 'Riben Shegencao' (Ophirrhiza japonica) of Rubiaceae family.


Subject(s)
China , Drugs, Chinese Herbal , Classification , Pharmacology , Therapeutic Uses , Materia Medica , Medicine, Chinese Traditional , Rubiaceae , Classification
2.
Journal of Zhejiang University. Science. B ; (12): 125-131, 2005.
Article in English | WPRIM | ID: wpr-316364

ABSTRACT

Epigallocatechin-3-gallate (EGCG) has shown remarkably anti-cancer activity, with its bioactivity being related to reactive conditions, such as pH and metal ions. The present study investigated the degradation of EGCG and its effect on prostate cancer cell in the presence of Cu2+. EGCG was incubated with prostate cancer cells, LNCaP, pretreated with or without Cu2+. EGCG in F-12 medium was quantified using HPLC and the viability of cells was assessed by gel electrophoresis, flow cytometry, and electron microscope. The results of HPLC showed that EGCG degraded completely within 12 h in F-12 medium with or without Cu2+. Gel electrophoresis and flow cytometry did not detect apoptosis of LNCaP cells when they were incubated with EGCG. Electron microscopy examination revealed that EGCG-Cu2+ complex led to damage of cytoplasm membrane in LNCaP cells. It was speculated that not EGCG, but its oxide and complex with Cu2+, are the bioactive components responsible for its cytotoxicity to LNCaP prostate cancer cells.


Subject(s)
Humans , Male , Anticarcinogenic Agents , Apoptosis , Catechin , Cell Line, Tumor , Cell Proliferation , Cell Survival , Copper , Metabolism , Dose-Response Relationship, Drug , Drug Combinations , Prostatic Neoplasms , Drug Therapy , Pathology
SELECTION OF CITATIONS
SEARCH DETAIL